“…Additionally, 31% ( n = 15) of the interventions targeted caregivers of patients with specific cancer diagnoses (i.e., breast (Christensen, 1983; Bultz et al, 2000; Northouse et al, 2005; Badger et al, 2007; Budin et al, 2008; Baucom et al, 2009), prostate (Manne et al, 2004; Campbell et al, 2006; Northouse et al, 2007), brain (Horowitz et al, 1996), hematopoietic stem cell transplantation (HSCT) (Bevans et al, 2010), and lung tumors (Goldberg & Wool, 1985), and pediatric cancers (Sahler et al, 2002; Stehl et al, 2009)). Additionally, 29% ( n = 14) of the interventions specifically targeted ICs of patients who had advanced disease/were receiving palliative care (Walsh & Schmidt, 2003; Cameron et al, 2004; Harding et al, 2004; Hudson et al, 2005, 2008; Keefe et al, 2005; McMillan et al, 2005; Milberg et al, 2005; Northouse et al, 2005; Carter, 2006; Kissane et al, 2006; Duggleby et al, 2007; Walsh et al, 2007; Bowman et al, 2009), whereas the remaining 71% ( n = 35) enrolled ICs of patients who were heterogeneous with regard to their disease stage.…”